Geoff Meacham, senior pharma analyst, BofA Securities, on what Merck's new Covid treatment could mean for the company and the industry, as a whole. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Steve Grasso and Nadine Terman.
By: CNBC Television
Title: What Merck's treatment means for the company, vaccine makers
Sourced From: www.youtube.com/watch?v=kDcHlNk-lVE
News.... browse around here